Literature DB >> 25938051

Retinal vessel diameters and their correlation with retinal nerve fiber layer thickness in patients with pseudoexfoliation syndrome.

Mehmet Cuneyt Ozmen1, Zeynep Aktas1, Burcin Kepez Yildiz1, Murat Hasanreisoglu1, Berati Hasanreisoglu1.   

Abstract

AIM: To compare retinal artery-vein diameters (RAVDs) of patients with pseudoexfoliation (PSX) syndrome with healthy controls and investigate the correlations between retinal nerve fiber layer (RNFL) thickness parameters and RAVDs.
METHODS: Seventeen eyes with PSX and 17 eyes of age-matched controls were included in the study. All participants underwent routine ophthalmological examination, Humphrey visual field and RNFL examination by using Stratus OCT. Retinal images were obtained by using a retinal camera (Topcon 501X). RAVDs were measured from inferior nasal, inferior temporal, superior nasal and superior temporal arcuates by using IMAGEnet software. Superior, inferior, nasal, temporal and average RNFL thicknesses were recorded. RAVDs and RNFL parameters in groups and correlations were analyzed by Mann-Whitney U and Spearmann correlation tests.
RESULTS: Only inferior quadrant and average RNFL thickness were detected thinner in the PSX group compared with control group (P=0.009, P=0.038, respectively). No statistically significant difference regarding RAVDs was found between two groups.
CONCLUSION: RAVDs seems to be comparable in the PSX and control group. RNFL is thinner in the inferior quadrant in the PSX group. RNFL thickness and RAVDs show significant correlations in both groups. This correlation doesn't seem to be specific to PSX.

Entities:  

Keywords:  pseudoexfoliation; retinal artery-vein diameters; retinal nerve fiber layer thickness

Year:  2015        PMID: 25938051      PMCID: PMC4413581          DOI: 10.3980/j.issn.2222-3959.2015.02.21

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  18 in total

1.  Short-term effects of a single intravitreal bevacizumab injection on retinal vessel calibre.

Authors:  Sinan Tatlipinar; Umut Aslı Dinç; N Melda Yenerel; Ebru Görgün
Journal:  Clin Exp Optom       Date:  2011-09-28       Impact factor: 2.742

2.  Retinal vessel diameter in normal and glaucomatous eyes: the Beijing eye study.

Authors:  Shuang Wang; Liang Xu; Yunshong Wang; Yaxing Wang; Jost B Jonas
Journal:  Clin Exp Ophthalmol       Date:  2007-12       Impact factor: 4.207

3.  Pilot study of optical coherence tomography measurement of retinal blood flow in retinal and optic nerve diseases.

Authors:  Yimin Wang; Amani A Fawzi; Rohit Varma; Alfredo A Sadun; Xinbo Zhang; Ou Tan; Joseph A Izatt; David Huang
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-11       Impact factor: 4.799

4.  Pseudoexfoliation as a risk factor for peripheral vascular disease: a case-control study.

Authors:  M R Praveen; S K Shah; A R Vasavada; R P Diwan; S M Shah; B R Zumkhawala; R Thomas
Journal:  Eye (Lond)       Date:  2010-12-03       Impact factor: 3.775

5.  Association of retinal vessel caliber and visual field defects in glaucoma.

Authors:  J K Hall; A P Andrews; R Walker; J R Piltz-Seymour
Journal:  Am J Ophthalmol       Date:  2001-12       Impact factor: 5.258

6.  Optic disc changes in normotensive persons with unilateral exfoliation syndrome: a 3-year follow-up study.

Authors:  P Puska; E Vesti; G Tomita; K Ishida; C Raitta
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1999-06       Impact factor: 3.117

7.  Detection of early glaucomatous damage in pseudo exfoliation syndrome by assessment of retinal nerve fiber layer thickness.

Authors:  Maha M Mohamed
Journal:  Middle East Afr J Ophthalmol       Date:  2009-07

Review 8.  Is exfoliation syndrome a sign of systemic vascular disease?

Authors:  Ahti Tarkkanen
Journal:  Acta Ophthalmol       Date:  2008-12       Impact factor: 3.761

9.  Analysis of retinal nerve fiber layer thickness in patients with pseudoexfoliation syndrome using optical coherence tomography.

Authors:  Nurşen Yüksel; Ozgül Altintaş; Mustafa Celik; Berna Ozkan; Yusuf Cağlar
Journal:  Ophthalmologica       Date:  2007       Impact factor: 3.250

10.  Retinal vascular occlusions occur more frequently in the more affected eye in exfoliation syndrome.

Authors:  T S Prata; I Rozenbaum; C G V de Moraes; V C Lima; J Liebmann; R Ritch
Journal:  Eye (Lond)       Date:  2009-06-26       Impact factor: 3.775

View more
  6 in total

1.  Comparisons of retinal vessel diameter and glaucomatous parameters between both eyes of subjects with clinically unilateral pseudoexfoliation syndrome.

Authors:  Yasuyuki Takai; Masaki Tanito; Tetsuro Omura; Ryo Kawasaki; Yumiko Kawasaki; Akihiro Ohira
Journal:  PLoS One       Date:  2017-06-23       Impact factor: 3.240

2.  Comparison of retinal nerve fiber layer thickness in patients having pseudo exfoliation syndrome with healthy adults.

Authors:  Naila Yasmeen; Nauroz Fatima
Journal:  Pak J Med Sci       Date:  2016 Nov-Dec       Impact factor: 1.088

3.  Analysis of Peripapillary and Macular Choroidal Thickness in Eyes with Pseudoexfoliative Glaucoma and Fellow Eyes.

Authors:  Fan Li; Qingli Shang; Guangxian Tang; Hengli Zhang; Xiaowei Yan; Lihua Ma; Yulei Geng; Qing Zhang
Journal:  J Ophthalmol       Date:  2020-06-07       Impact factor: 1.909

4.  Clinical Analysis of Macular Choroidal Thickness in Pseudoexfoliative Glaucoma and Primary Open-Angle Glaucoma.

Authors:  Fan Li; Yiming Huo; Lihua Ma; Qing Zhang; Hengli Zhang; Xiaowei Yan; Yulei Geng; Guangxian Tang
Journal:  J Ophthalmol       Date:  2021-11-16       Impact factor: 1.909

5.  The Effects of Trabeculectomy on Pseudoexfoliation Glaucoma and Primary Open-Angle Glaucoma.

Authors:  Fan Li; Guangxian Tang; Hengli Zhang; Xiaowei Yan; Lihua Ma; Yulei Geng
Journal:  J Ophthalmol       Date:  2020-03-23       Impact factor: 1.909

Review 6.  Spatial and spatio-temporal statistical analyses of retinal images: a review of methods and applications.

Authors:  Wenyue Zhu; Ruwanthi Kolamunnage-Dona; Yalin Zheng; Simon Harding; Gabriela Czanner
Journal:  BMJ Open Ophthalmol       Date:  2020-05-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.